Vega Investment Solutions Buys New Position in Cardinal Health, Inc. $CAH

Vega Investment Solutions purchased a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 14,361 shares of the company's stock, valued at approximately $3,412,000.

Other large investors also recently modified their holdings of the company. Bank of New York Mellon Corp bought a new stake in Cardinal Health during the 2nd quarter valued at $308,640,000. Kornitzer Capital Management Inc. KS increased its position in shares of Cardinal Health by 100.8% during the fourth quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company's stock worth $3,733,000 after acquiring an additional 9,120 shares in the last quarter. First Nebraska Trust Co acquired a new stake in shares of Cardinal Health in the 2nd quarter worth about $20,050,000. Byrne Financial Freedom LLC bought a new position in Cardinal Health in the 4th quarter valued at about $1,574,000. Finally, Belleair Asset Management LLC acquired a new position in Cardinal Health during the 4th quarter valued at about $1,100,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on CAH shares. Leerink Partners set a $292.00 target price on Cardinal Health in a report on Tuesday, August 11th. Zacks Research lowered shares of Cardinal Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, June 12th. Royal Bank Of Canada assumed coverage on shares of Cardinal Health in a research report on Wednesday, August 19th. They set an "outperform" rating and a $276.00 price target on the stock. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, July 4th. Finally, Barclays lifted their target price on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an "overweight" rating in a research report on Thursday, August 13th. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $266.56.

Insiders Place Their Bets

In related news, CAO Mary C. Scherer sold 2,302 shares of the company's stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $237.39, for a total transaction of $546,471.78. Following the sale, the chief accounting officer directly owned 2,811 shares in the company, valued at approximately $667,303.29. This represents a 45.02% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Deborah Weitzman sold 7,354 shares of the firm's stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the completion of the transaction, the chief executive officer directly owned 77,901 shares of the company's stock, valued at approximately $18,341,790.45. This trade represents a 8.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 210,271 shares of company stock worth $49,626,657 in the last ninety days. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Stock Performance

NYSE CAH opened at $232.13 on Tuesday. The company has a market capitalization of $53.99 billion, a PE ratio of 32.11, a price-to-earnings-growth ratio of 1.23 and a beta of 0.49. Cardinal Health, Inc. has a 52-week low of $145.87 and a 52-week high of $258.30. The company has a 50-day simple moving average of $232.13 and a 200 day simple moving average of $217.96.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company had revenue of $63.67 billion during the quarter, compared to analyst estimates of $65.15 billion. During the same quarter last year, the business posted $2.08 EPS. Cardinal Health's quarterly revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, analysts forecast that Cardinal Health, Inc. will post 12.54 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health's dividend payout ratio (DPR) is 28.49%.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source